Kestine Flash (Ebastine)

Ebastine is a selective peripheral H1‑receptor antagonist. After oral absorption, it is metabolised to its active form, carebastine, which binds to H1 receptors on mast cells, basophils and other tissues, preventing histamine from triggering the cascade that leads to vasodilation, increased vascular permeability and sensory nerve stimulation. This inhibition reduces the classic signs of allergic inflammation without significant central nervous system sedation.

The prescribed dose of Kestine Flash is determined by the treating physician based on the patient’s age, clinical condition and response to therapy. In most adult cases, a single oral dose is administered once daily, but the exact amount and frequency must follow the prescriber’s instructions and the product’s labeling.

The safety of ebastine in pregnancy and lactation has not been conclusively established. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss individual circumstances and consider alternative treatments when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Kestine Flash. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with first‑generation H1 antagonists, ebastine offers similar efficacy for allergic symptoms but with a lower incidence of sedation and anticholinergic effects because it does not readily cross the blood‑brain barrier. Within the second‑generation class, its potency and duration of action are comparable to cetirizine and loratadine, making it a suitable alternative when a non‑sedating option is desired.

Store Kestine Flash at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date indicated on the label.

Kestine Flash is taken orally, usually with a glass of water. It may be taken with or without food, but consistent administration with respect to meals can help maintain stable plasma concentrations. Patients should follow the dosing schedule prescribed by their healthcare professional.

Although rare, serious adverse reactions can include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, hepatic enzyme elevations and, in exceptional cases, cardiac arrhythmias. Any signs of swelling, rash, jaundice or irregular heartbeat require immediate medical attention.

Kestine Flash is contraindicated in individuals with known hypersensitivity to ebastine or any of the excipients in the formulation. Caution is also advised for patients with severe hepatic impairment, as metabolism may be altered, and for those taking potent CYP3A4 inhibitors, which can increase drug exposure.